American Well Corp

American Well Corporation reappointed Stephen Schlegel as a Class III director for a term expiring at the 2029 annual meeting of stockholders. This re-appointment followed his resignation as a Class II director and was solely to rebalance the Board's classes to comply with NYSE listing standards. The company confirmed there were no disagreements, and Mr. Schlegel's committee assignments and compensatory arrangements were not changed.

Amwell announced positive results from a large-scale, independently led clinical trial of its SilverCloud digital behavioral health solution, funded by the National Institute of Mental Health. The study, involving 6,205 high-risk students across 26 U.S. colleges, found that individuals offered SilverCloud were over twice as likely to engage (74.4% vs. 30.2% for traditional care). Participants also showed a 3.8% lower prevalence of mental disorders at two years, potentially avoiding up to $1.18 million in mental health-related costs within the study sample.

Dr. Roy Schoenberg resigned from American Well Corporation's Board of Directors on May 6, 2026, effective immediately. His resignation is due to a new employment opportunity and was not the result of any disagreement with the company. American Well expressed gratitude for his nearly twenty years of leadership and vision as a co-founder and Executive Vice Chairman, acknowledging his enduring impact on the company's growth and success.

American Well reported a significant reduction in net loss for Q1 2026, narrowing to $10.9 million from $18.7 million in Q1 2025, and a substantial decrease in cash used in operating activities. This improvement occurred despite an 18% decline in total revenue to $54.9 million. The company also recognized an additional $7.0 million gain from a prior divestiture and recorded a $3.4 million impairment on a right-of-use asset.

Amwell announced its financial results for the first quarter ended March 31, 2026, reporting total revenue of $54.9 million, which exceeded its financial guidance. The company showed a favorable trajectory in its financial performance, with a net loss of ($10.3) million and Adjusted EBITDA of ($3.1) million, both significantly improved from the previous quarter. Amwell reaffirmed its 2026 revenue guidance and updated its Adjusted EBITDA outlook, reiterating its objective to achieve positive cash flow from operations in the fourth quarter of 2026.

Amwell announced its financial results for the first quarter ended March 31, 2026, which are available on its investor relations website. The company will host a conference call today at 5 p.m. ET to discuss these results, with a live audio webcast and a replay available for approximately 90 days.

Amwell (NYSE: AMWL) announced it will report its first quarter 2026 operating results after market close on Tuesday, May 5. Following the earnings release, the management team will host a live conference call and webcast at 5 p.m. ET to discuss the results and provide a business update. The full report and webcast will be accessible via the Investors section of the company's website.